Skip to main content

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Participation in Upcoming Investor Conferences

Trxade Group (NASDAQ: MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, will be participating in three investor conferences scheduled in March 2021. In all three conferences, Trxade Group CEO Suren Ajjarapu will present valuable information and insights about the company for conference participants. In addition, he is scheduled to participate in one-on-one meetings during each event. Conferences in which Ajjarapu is scheduled to participate include the two-day H.C. Wainwright Global Life Sciences Conference, slated for March 9-10, 2021; the three-day Roth Growth Stock Conference, scheduled for March 15–17, 2021; and the two-day Maxim Group Emerging Growth Conference, which will be held March 17–18, 2021. All three conferences are virtual, online events.

To view the full press release, visit https://ibn.fm/c6MyX

About Trxade Group Inc.

Trxade Group is a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug-procurement marketplace serving a total of 11,800-plus members nationwide and fostering price transparency as well as the Bonum Health brand, offering patient centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.